Growth Paths / Genetics & Biotechnology
ExpertFREESkills

Genetics & Biotechnology

Modern genetics is computational before it is wet. The data is public, the tools are free. Your proof is what you understand about the output.

NCBI, Ensembl, and a thousand public genomes are free. BLAST, PhyML, and DESeq2 are free. The bottleneck in modern genetics research is not data or tools — it is knowing what the output means and being able to defend that interpretation to someone who has spent their career looking at this data. This path is postgraduate because bioinformatics analysis without prior biology and biochemistry produces pattern-matching, not genetics. The entry point is a real bioinformatics pipeline on a named public dataset, and the path builds from analysis to interpretation to application to ethics.

2 required outcomes44 weeksCredential on completion
Enroll — it's free

Path outcomes

10
Skills

Bioinformatics Analysis Pipeline

Required. Real bioinformatics analysis on a named public dataset from NCBI, Ensembl, or equivalent: BLAST sequence alignment, multiple sequence alignment (MUSCLE or MAFFT), phylogenetic tree construction (PhyML or IQ-TREE), variant annotation (Ensembl VEP or ClinVar), or RNA-seq differential expression (DESeq2 or edgeR). Submitted code must be independently runnable. Reviewed by a geneticist or bioinformatician who examines parameter choices and asks why specific settings were chosen over alternatives. All tools and data are free.

Enroll in outcome →
20
Skills

Genetic Data Interpretation

Required. Interpret real genetic data from a named public source: annotate variants using ClinVar and Ensembl VEP (both free), interpret a GWAS result from a published study tracing a named variant through statistical and functional evidence, or analyse sequencing results for a named genetic question. Document the evidence base for each interpretation claim. Reviewer presents an unseen variant of uncertain significance and asks you to classify it using ACMG/AMP criteria — requiring real-time reasoning, not recall. Builds on bioinformatics analysis (seq 10).

Enroll in outcome →
30
SkillsOptional

Biotechnology Application Case Analysis

Elective. Case analysis of a specific named biotechnology application: a named CRISPR therapy in clinical trials (ClinicalTrials.gov registry), a named synthetic biology product, or a named agricultural biotech product with a published safety assessment. Three dimensions: (1) scientific validity — what does the evidence actually show? (2) regulatory status — what approvals exist and what gaps remain? (3) ethical implications — contested trade-offs with an explicitly named ethical framework. Reviewer challenges whether the evidence you cited is sufficient to support your efficacy conclusions.

Enroll in outcome →
40
SkillsOptional

Genetics Ethics and Policy Analysis

Elective. Analyse a real genetics ethics case using an explicitly named ethical framework: DTC genetic testing regulation (named product + jurisdiction), gene drive proposals (named ecosystem + target species), germline editing policy (named national framework vs. ISSCR 2021 guidelines), or prenatal genetic diagnosis policy (named condition + jurisdiction). Apply the framework explicitly — not just describe it — and reach a substantive conclusion. Reviewer challenges with a real counter-example requiring reasoning about a specific case you may not have prepared for.

Enroll in outcome →
50
LearningOptional

Write and Publish a Research Paper

Elective capstone. A full genetics or bioinformatics research paper accepted by a peer-reviewed journal or conference. The peer review system provides external adversarial verification. The research paper builds on the bioinformatics pipeline (seq 10) and interpretation (seq 20) — the analysis becomes the Methods and Results of a publishable paper. Not a separate investigation.

Enroll in outcome →

Free resources for this path

Every resource listed here is free. No affiliate links. No sponsored placements.

Free access to BLAST (sequence alignment), GenBank (sequence repository), SRA (short read archive), ClinVar (variant significance database), and dbSNP (SNP database). Use for the bioinformatics analysis step (BLAST alignment on a named public sequence) and the genetic data interpretation step (ClinVar variant annotation). The authoritative free resource for sequence data and clinical variant databases.

Free access to annotated genomes from hundreds of species, variant annotations via the Ensembl Variant Effect Predictor (VEP — free web tool and API), and downloadable genome sequence data. Use for the bioinformatics analysis step (genome-scale alignment and annotation) and the genetic data interpretation step (VEP annotation of your variant set). VEP is the standard tool for variant functional consequence prediction in published research.

Free registry of all clinical trials registered in the United States, including CRISPR therapies, gene therapies, and biotechnology products. Use for the biotechnology case analysis step — find a named IND for a specific CRISPR therapy, read the study protocol, and analyse the scientific validity and regulatory status. Each trial has a unique NCT number for citation.

Free online access to a rigorous textbook on bioinformatics algorithms — sequence alignment, phylogenetics, genome assembly, and more. Use to understand the mathematical foundations of the tools you use in the bioinformatics analysis step: knowing what BLAST's Smith-Waterman alignment is actually computing lets you make informed parameter choices and explain them to a reviewer.

Growth Path Credential

Complete all 2 required outcomes to earn your immutable, publicly verifiable Growth Path Credential.

We use analytics to improve Powstik. No ads, ever.